Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Water → Remogliflozin Etabonate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Water | HCID 962 | — |
| 반응물 | Ethyl chloroformate | HCID 10928 | — |
| 반응물 | 2-Hydroxy-1,2,3-propanetricarboxylic acid hydrate (1:1) | HCID 22230 | — |
| 반응물 | Remogliflozin | HCID 9846588 | — |
| 용매 | 2,4,6-Trimethylpyridine | HCID 7953 | — |
| 생성물 | Remogliflozin Etabonate | HCID 9871420 | 72.4% |
반응 단계
To a solution of 3-(β-D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole (0.10 g) in 2,4,6-trimethylpyridine (1 mL) was added ethyl chloroformate (0.072 g), and the mixture was stirred at room temperature overnight. To the reaction mixture were added citric acid monohydrate (3.3 g) and water, and the resulting mixture was purified by ODS solid phase extraction (washing solvent: distilled water, eluent: methanol). Further purification by column chromatography on silica gel (eluent: dichloromethane/methanol=1011) and recrystalization (recrystalization solvent: ethyl acetate/hexane=1/3) afforded 3-(6-O-ethoxycarbonyl-β-D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole (0.084 g).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07084123B2 |
| 출처 데이터셋 | uspto-grants-2006_08 |
| ORD ID | ord-b17bdad534cf48f2a7bb48b047be9ec0 |
| 출처 메모 | uspto-grants-2006_08 |